Gold, Benjamin D.
Pilmer, Betsy
Kierkuś, Jaroslaw
Hunt, Barbara
Perez, Maria Claudia
Gremse, David
Clinical trials referenced in this document:
Documents that mention this clinical trial
Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
https://doi.org/10.1007/s10620-017-4743-3
Funding for this research was provided by:
Takeda Pharmaceuticals
Article History
Received: 13 April 2017
Accepted: 30 August 2017
First Online: 15 September 2017
Compliance with ethical standards
:
: Betsy Pilmer was an employee of Takeda Development Center Americas, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals America, Inc. Barbara Hunt and Maria Claudia Perez are employees of Takeda Development Center Americas, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals America, Inc. Benjamin D. Gold was a consultant for Takeda Pharmaceuticals of North America. Jaroslaw Kierkuś and David Gremse have no relevant disclosures.
: This research involved human participants and was conducted according to the principles described in the Declaration of Helsinki, International Conference on Harmonization Harmonized Tripartite Guideline for Good Clinical Practice. Patient assent and parent/guardian consent were obtained prior to commencement of study procedures. The study protocol was reviewed and approved by Institutional Review Boards and Independent Ethics Committees.